NOTE 10. GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill
The following table summarizes the changes in the carrying amount of goodwill, net of adjustments for discontinued operations:
(in millions) | Total | |||
Balance at June 30, 2011 |
$ | 2,933 | ||
Goodwill Acquired, Net of Purchase Price Adjustments |
116 | |||
Foreign Currency Translation Adjustments |
(10 | ) | ||
|
|
|||
Balance at June 30, 2012 |
3,039 | |||
Goodwill Acquired, Net of Purchase Price Adjustments |
41 | |||
Foreign Currency Translation Adjustments |
1 | |||
|
|
|||
Balance at June 30, 2013 |
$ | 3,081 | ||
|
|
As of June 30, 2013, goodwill for the Medical Systems segment and the Procedural Solutions segment was $2,103 million and $978 million, respectively. The amount set forth above for goodwill acquired reflects the acquisition of Intermed, which we completed on November 14, 2012.
As of June 30, 2012, goodwill for the Medical Systems segment and the Procedural Solutions segment was $2,066 million and $973 million, respectively. The amount set forth above for goodwill acquired in fiscal year 2012 reflects the acquisition of Rowa, which we completed on August 1, 2011, the acquisition of PHACTS, which we completed on April 2, 2012, and the acquisition of UK Medical, which we completed on June 1, 2012.
As discussed in note 1 to the consolidated financial statements, during the quarter ended September 30, 2012, we combined our respiratory diagnostics products with our Respiratory Technologies business line, which is included in the Medical Systems segment. As a result, goodwill was reassigned to the Medical Systems and Procedural Solutions operating segments using the relative fair value allocation and is reflected retrospectively.
Intangible Assets
Intangible assets with definite lives are amortized over their useful lives which range from 3 to 20 years. The detail of intangible assets by class is as follows:
(in millions) |
Weighted
Average |
Gross Intangible |
Accumulated Amortization |
Net Intangible |
||||||||||
June 30, 2013 |
||||||||||||||
Unamortized Intangibles: |
||||||||||||||
In-Process Research and Development |
Indefinite | $ | 45 | $ | — | $ | 45 | |||||||
Trademarks |
Indefinite | 307 | — | 307 | ||||||||||
|
|
|
|
|
|
|||||||||
Total Unamortized Intangibles |
352 | — | 352 | |||||||||||
Amortized Intangibles: |
||||||||||||||
Trademarks and Patents |
11 | 88 | 47 | 41 | ||||||||||
Developed Technology |
9 | 368 | 200 | 168 | ||||||||||
Customer Relationships |
16 | 480 | 275 | 205 | ||||||||||
Other |
7 | 61 | 34 | 27 | ||||||||||
|
|
|
|
|
|
|||||||||
Total Amortized Intangibles |
12 | 997 | 556 | 441 | ||||||||||
|
|
|
|
|
|
|||||||||
Total Intangibles |
$ | 1,349 | $ | 556 | $ | 793 | ||||||||
|
|
|
|
|
|
|||||||||
June 30, 20121 |
||||||||||||||
Unamortized Intangibles: |
||||||||||||||
In-Process Research and Development |
Indefinite | $ | 45 | $ | — | $ | 45 | |||||||
Trademarks |
Indefinite | 307 | — | 307 | ||||||||||
|
|
|
|
|
|
|||||||||
Total Unamortized Intangibles |
352 | — | 352 | |||||||||||
Amortized Intangibles: |
||||||||||||||
Trademarks and Patents |
11 | 86 | 41 | 45 | ||||||||||
Developed Technology |
9 | 353 | 154 | 199 | ||||||||||
Customer Relationships |
16 | 478 | 253 | 225 | ||||||||||
Other |
8 | 41 | 31 | 10 | ||||||||||
|
|
|
|
|
|
|||||||||
Total Amortized Intangibles |
12 | 958 | 479 | 479 | ||||||||||
|
|
|
|
|
|
|||||||||
Total Intangibles |
$ | 1,310 | $ | 479 | $ | 831 | ||||||||
|
|
|
|
|
|
1 |
Amounts have been adjusted for discontinued operations. See note 2 to the consolidated financial statements. |
Amortization expense for the three years ended June 30, 2013, 2012 and 2011 is as follows, net of adjustments for discontinued operations:
Fiscal Year Ended June 30, | ||||||||||||
(in millions) | 2013 | 2012 | 2011 | |||||||||
Amortization Expense |
$ | 75 | $ | 89 | $ | 80 |
Amortization expense for each of the next five fiscal years is estimated to be:
(in millions) | 2014 | 2015 | 2016 | 2017 | 2018 | |||||||||||||||
Amortization Expense |
$ | 74 | $ | 61 | $ | 59 | $ | 54 | $ | 44 |